Related Experiment Video
Updated: Jul 7, 2026

10:48
Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression
Published on: May 15, 2014
Introduction: vaccination against smallpox in the posteradication era
Louisa E Chapman1, Gina T Mootrey, Linda J Neff
1Centers for Disease Control and Prevention, Atlanta, Georgia, USA. lec3@cdc.gov
Summary
The national smallpox vaccination program faced challenges, but this review focuses on vaccine safety and adverse events. Key lessons learned from policy and implementation are discussed.
Area of Science:
- Public Health Policy
- Infectious Disease Control
- Vaccinology
Background:
- The national smallpox vaccination program's implementation context.
- Significance of policy, programmatic, and scientific challenges.
- Focus on vaccine-associated adverse events and vaccine safety.
Discussion:
- Complex and varied challenges encountered during program execution.
- Observations and lessons learned from the national vaccination effort.
- Analysis of vaccine safety protocols and outcomes.
Key Insights:
- Understanding challenges in large-scale vaccination programs.
- Importance of monitoring vaccine-associated adverse events.
- Data-driven insights into vaccine safety and efficacy.
Outlook:
- Improving future vaccination strategies.
- Enhancing public health preparedness for infectious diseases.
- Continued research in vaccine safety and adverse event management.
Related Concept Videos
Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Vaccinations
Overview
Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Chickenpox
Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

